Congressional trading data shows lawmakers placing 34 trades across names with earnings due in early February, pointing to a clear but mixed positioning ahead of the reports. The activity clusters in technology, consumer cyclical, communication services and healthcare, with Rep. Ro Khanna accounting for the largest share of disclosed moves.
Khanna sold shares of TENB seven times and GPK six times in the run-up to their quarterly updates. He also exited CART five times, APP three times and INTC three times. These sales come as analysts project TENB to deliver roughly 55 cents per share on $282-294 million in revenue, following a strong Q3 beat of 63 cents EPS. GPK carries lighter expectations around 22 cents EPS on approximately $2.12 billion revenue after its most recent print showed a narrow beat and positive stock reaction. The volume of sales by one member in these specific tickers stands out as the data's clearest signal.
On the buy side Khanna added to MRVL three times, a semiconductor play tied to data center demand. Rep. Gilbert Cisneros purchased ARGX three times and both members bought COO three times. ARGX, a biotech developing therapies for severe autoimmune conditions, and COO, which supplies vision correction and surgical tools, represent the healthcare tilt in this earnings watch list. Additional sales of MSFT by Sen. Sheldon Whitehouse, Sen. Shelley M Capito and Khanna round out the three-trade names.
The split activity, 20 buys against 10 sells in the broadest cohort and then targeted exits in tech and consumer cyclical, suggests lawmakers may be trimming exposure where valuations appear stretched while adding to sectors with visible growth pipelines. February reports will test whether these moves prove prescient. TENB maintains a consistent beat rate and upward estimate revisions, yet the repeated sales precede that test. GPK faces margin pressure from input costs even after its latest print lifted shares.
With multiple members including Thomas Suozzi, Darrell Issa, Suzan DelBene, Mike Kelly, Rudy Yakym, Ann Wagner and Kevin Hern also appearing in the broader activity, the filings capture a cross-aisle look at how Washington portfolios are adjusting as quarterly results loom. The overlap in timing between the trades and the earnings calendar continues a pattern visible in recent cycles, though causation remains unproven. Investors often scan these disclosures for directional clues on sectors or specific companies.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.